InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: J_Dean post# 5132

Saturday, 02/23/2019 10:47:09 PM

Saturday, February 23, 2019 10:47:09 PM

Post# of 6939
A low ball figure would be less than $1.5 billion market cap right now before approval double that after the first approval. One can deduce that by similar deals and market caps of similar Phase 3 oncology biotechs. I think you can do the math on the price per share.